Drug intelligence / Profile preview

ethyl 3-[4-(aminosulfonyl)phenyl]propanoate

Development stage: Unknown
Modality: Small Molecules

Overview

Ethyl 3-[4-(aminosulfonyl)phenyl]propanoate is a small molecule belonging to the class of benzenesulfonamides. It is an experimental compound that acts as an inhibitor of carbonic anhydrase enzymes (specifically carbonic anhydrase 1 and carbonic anhydrase 2). The drug has not been approved for any indication and has not advanced beyond preclinical or early research stages. Its primary mechanism involves inhibition of the target enzymes involved in various physiological processes such as acid-base balance and fluid secretion[1][2][3][4].

Other names: ethyl 3-[4-(aminosulfonyl)phenyl]propanoateethyl 3-(4-sulfamoylphenyl)propanoate4-propyl benzenesulfonamide ethyl ester

Targets

CA1 (Carbonic anhydrase 1)CA2 (Carbonic Anhydrase 2)

Beyond the preview

Go deeper on ethyl 3-[4-(aminosulfonyl)phenyl]propanoate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethyl 3-[4-(aminosulfonyl)phenyl]propanoate.

Explore the full profile